I agree we have a preventative treatment for a cancer and not everyone takes it. What conclusions do you draw from this point as it relates to this thread (or in general)?
Personally, I'm surprised that uptake is so fast for a relatively new and elective treatment. Even moreso when considering that it addresses a rare disease that effects people many decades later.
https://www.cdc.gov/hpv/partners/outreach-hcp/hpv-coverage.h....
This isn't surprising because the CDC shows adoption going up a few percent per year. This year over year increase is more or less what you would expect given we are still in the adoption phase of this new medicine.[2] Eventually this increase will stall out with some people refusing to use it, but we aren't there yet.